{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:58:47Z","timestamp":1790636327581,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Boehringer Ingelheim Pharmaceuticals, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04420-x","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:56:01Z","timestamp":1783331761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors associated with delayed diagnosis of fibrotic interstitial lung disease: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Hyun J.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharashchandra","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Pimple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Petterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana A.","family":"Vaughn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Lamerato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"4420_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/jcm7120476","volume":"7","author":"O Kalchiem-Dekel","year":"2018","unstructured":"Kalchiem-Dekel O, Galvin JR, Burke AP, Atamas SP, Todd NW. Interstitial Lung Disease and Pulmonary Fibrosis: A Practical Approach for General Medicine Physicians with Focus on the Medical History. J Clin Med. 2018;7:476.","journal-title":"J Clin Med"},{"key":"4420_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"key":"4420_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12931-019-1022-1","volume":"20","author":"M Kolb","year":"2019","unstructured":"Kolb M, Vasakova M. The natural history of progressive fibrosing interstitial lung diseases. Respir Res. 2019;20:57.","journal-title":"Respir Res"},{"key":"4420_CR4","unstructured":"Interstitial Lung Disease. Cleveland Clinic. 2024. https:\/\/my.clevelandclinic.org\/health\/diseases\/17809-interstitial-lung-disease. Accessed 30 May 2024."},{"key":"4420_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12890-017-0560-x","volume":"18","author":"GP Cosgrove","year":"2018","unstructured":"Cosgrove GP, Bianchi P, Danese S, Lederer DJ. Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey. BMC Pulm Med. 2018;18:9.","journal-title":"BMC Pulm Med"},{"key":"4420_CR6","doi-asserted-by":"crossref","unstructured":"Desai SR, Prosch H, Galvin JR. Plain film and HRCT diagnosis of interstitial lung disease. In: Hodler J, Kubik-Huch RA, von Schulthess GK, editors. Diseases of the Chest, Breast, Heart and Vessels 2019\u20132022. Diagnostic and Interventional Imaging. Cham, Switzerland: Springer; 2019.","DOI":"10.1007\/978-3-030-11149-6_4"},{"key":"4420_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S2213-2600(16)30325-3","volume":"5","author":"FJ Martinez","year":"2017","unstructured":"Martinez FJ, Chisholm A, Collard HR, Flaherty KR, Myers J, Raghu G, et al. The diagnosis of idiopathic pulmonary fibrosis: current and future approaches. Lancet Respir Med. 2017;5:61\u201371.","journal-title":"Lancet Respir Med"},{"key":"4420_CR8","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1007\/s12325-021-01786-8","volume":"38","author":"AL Olson","year":"2021","unstructured":"Olson AL, Patnaik P, Hartmann N, Bohn RL, Garry EM, Wallace L. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis. Adv Ther. 2021;38:4100\u201314.","journal-title":"Adv Ther"},{"key":"4420_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12890-023-02565-7","volume":"23","author":"MB Herberts","year":"2023","unstructured":"Herberts MB, Teague TT, Thao V, Sangaralingham LR, Henk HJ, Hovde KT, et al. Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment. BMC Pulm Med. 2023;23:281.","journal-title":"BMC Pulm Med"},{"key":"4420_CR10","unstructured":"CMS Manual System. Pub 100-04 Medicare Claims Processing. Centers for Medicare & Medicaid Services (CMS). 2010. https:\/\/www.cms.gov\/Regulations-and-Guidance\/Guidance\/Transmittals\/downloads\/R2121CP.pdf. Accessed 16 Feb 2024."},{"key":"4420_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1164\/rccm.202209-1817ED","volume":"207","author":"MS Wijsenbeek","year":"2023","unstructured":"Wijsenbeek MS, Brusselle GG. Risk Stratifying Interstitial Lung Abnormalities to Guide Early Diagnosis of Interstitial Lung Diseases. Am J Respir Crit Care Med. 2023;207:9\u201311.","journal-title":"Am J Respir Crit Care Med"},{"key":"4420_CR12","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1513\/AnnalsATS.202102-222OC","volume":"19","author":"D Singer","year":"2022","unstructured":"Singer D, Bengtson LGS, Conoscenti CS, Laouri M, Shetty SS, Anderson AJ, Brown KK. Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States. Ann Am Thorac Soc. 2022;19:1112\u201321.","journal-title":"Ann Am Thorac Soc"},{"key":"4420_CR13","first-page":"A1412","volume":"207","author":"P Pimple","year":"2023","unstructured":"Pimple P, Berger A, Shah S, Hong M, Hicks W, Bassel M, et al. Development and validation of case-finding algorithms for use in secondary electronic health databases to identify patients with fibrotic interstitial lung disease. Am J Respir Crit Care Med. 2023;207:A1412.","journal-title":"Am J Respir Crit Care Med"},{"key":"4420_CR14","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1080\/03007995.2019.1647040","volume":"35","author":"M Wijsenbeek","year":"2019","unstructured":"Wijsenbeek M, Kreuter M, Olson A, Fischer A, Bendstrup E, Wells CD, et al. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management. Curr Med Res Opin. 2019;35:2015\u201324.","journal-title":"Curr Med Res Opin"},{"key":"4420_CR15","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1164\/rccm.201104-0668OC","volume":"184","author":"DJ Lamas","year":"2011","unstructured":"Lamas DJ, Kawut SM, Bagiella E, Philip N, Arcasoy SM, Lederer DJ. Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. Am J Respir Crit Care Med. 2011;184:842\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"4420_CR16","first-page":"509","volume":"15","author":"A Berger","year":"2009","unstructured":"Berger A, Edelsberg J, Inglese GW, Bhattacharyya SK, Oster G. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease. Am J Manag Care. 2009;15:509\u201318.","journal-title":"Am J Manag Care"},{"key":"4420_CR17","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2147\/CLEP.S54815","volume":"5","author":"B Ley","year":"2013","unstructured":"Ley B, Collard HR. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol. 2013;5:483\u201392.","journal-title":"Clin Epidemiol"},{"key":"4420_CR18","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1093\/bioinformatics\/btaa046","volume":"36","author":"S Parvandeh","year":"2020","unstructured":"Parvandeh S, Yeh HW, Paulus MP, McKinney BA. Consensus features nested cross-validation. Bioinformatics. 2020;36:3093\u20138.","journal-title":"Bioinformatics"},{"key":"4420_CR19","doi-asserted-by":"publisher","first-page":"115222","DOI":"10.1016\/j.eswa.2021.115222","volume":"182","author":"J Wainer","year":"2021","unstructured":"Wainer J, Cawley G. Nested cross-validation when selecting classifiers is overzealous for most practical applications. Expert Syst Appl. 2021;182:115222.","journal-title":"Expert Syst Appl"},{"key":"4420_CR20","doi-asserted-by":"publisher","first-page":"e0224365","DOI":"10.1371\/journal.pone.0224365","volume":"14","author":"A Vabalas","year":"2019","unstructured":"Vabalas A, Gowen E, Poliakoff E, Casson AJ. Machine learning algorithm validation with a limited sample size. PLoS ONE. 2019;14:e0224365.","journal-title":"PLoS ONE"},{"key":"4420_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1479972311416382","volume":"8","author":"G Schoenheit","year":"2011","unstructured":"Schoenheit G, Becattelli I, Cohen AH. Living with idiopathic pulmonary fibrosis: an in-depth qualitative survey of European patients. Chron Respir Dis. 2011;8:225\u201331.","journal-title":"Chron Respir Dis"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04420-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04420-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04420-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:32:43Z","timestamp":1790634763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04420-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4420"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04420-x","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Henry Ford Health Institutional Review Board (approval no. 15094). The study was retrospective in nature, relied exclusively on information contained in patients\u2019 medical records, and abstracted such data on a pseudo-anonymized basis, and the institutional review board granted a waiver for consent to participate.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.R., C.P., C.L., and A.B. are employees of Thermo Fisher Scientific and members of the PPD\u2122 business, hired by Boehringer Ingelheim to consult on this project. At the time this research was conducted, Su.S. and W.H. also were employees of Thermo Fisher Scientific and members of the PPD\u2122 business. I.A.V. is an employee of Henry Ford Health, which received compensation from Boehringer Ingelheim for work relating to this study. At the time this research was conducted, L.L. also was an employee of Henry Ford Health. H.J.K. reports grants paid to her institution from Boehringer Ingelheim, FibroGen, Galapagos, the National Institutes of Health, Roche Genentech, and United Therapeutics. Further, she is a site investigator and member of the Publications Committee for the IPF-PRO\/ILD-PRO Registry. P.P., Sh.S., and A.O. are employees of Boehringer Ingelheim.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"435"}}